Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Rev Med Interne ; 39(1): 34-41, 2018 Jan.
Artigo em Francês | MEDLINE | ID: mdl-28302338

RESUMO

The antiphospholipid syndrome is a bioclinical entity defined by thrombosis and/or obstetrical complications in the presence, at least 12 weeks apart, of antiphospholipid antibodies detected by coagulation test (lupus anticoagulant) or immunological assays (anticardiolipin, anti-ß2-glycoprotein I antibodies). Biological markers' improvement such as anti-phosphatidylserine/prothrombin and biological score should allow better patients' management and preventive therapeutic for thrombosis and obstetrical complications. This review describes different types of antibodies, link between biological profile and risk level of thrombosis events/obstetrical complications and gives practical advice to interpret biological results.


Assuntos
Síndrome Antifosfolipídica/diagnóstico , Técnicas de Laboratório Clínico/métodos , Prática Profissional , Síndrome Antifosfolipídica/sangue , Síndrome Antifosfolipídica/terapia , Biomarcadores/sangue , Humanos , Prática Profissional/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA